DNTH (Dianthus Therapeutics) Accumulated Depreciation : $-0.19 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Dianthus Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Dianthus Therapeutics's quarterly accumulated depreciation increased from Jun. 2024 ($-0.14 Mil) to Sep. 2024 ($-0.17 Mil) and increased from Sep. 2024 ($-0.17 Mil) to Dec. 2024 ($-0.19 Mil).

Dianthus Therapeutics's annual accumulated depreciation increased from Dec. 2022 ($-0.03 Mil) to Dec. 2023 ($-0.10 Mil) and increased from Dec. 2023 ($-0.10 Mil) to Dec. 2024 ($-0.19 Mil).

Dianthus Therapeutics Accumulated Depreciation Historical Data

The historical data trend for Dianthus Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dianthus Therapeutics Accumulated Depreciation Chart

Dianthus Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

-0.03

-0.10

-0.19

Dianthus Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accumulated Depreciation	Get a 7-Day Free Trial						-0.10	-0.12	-0.14	-0.17	-0.19

Dianthus Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Dianthus Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Dianthus Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Dianthus Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dianthus Therapeutics Inc (NAS:DNTH) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

87E:Germany

Address

7 Times Square, 43rd Floor, New York, NY, USA, 10036

Website

https://www.dianthustx.com

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.